VAV2 and breast carcinoma: Mechanistically, the overexpression of MST3 increases the phosphorylation of VAV2, and subsequently promotes VAV2-mediated activation of the Rac1-cyclin D1 signaling pathway that is required for the growth of breast cancer cells.